Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine December 2014, 55 (12) 8A;
  • Article
  • Info & Metrics
  • PDF
Loading

Theranostic nanoparticles: Chen and colleagues provide an overview of the current and prospective status of these multifunctional nanosystems, including challenges in highly specific targeting of tumors.

Page 1919

Customer satisfaction: Hicks offers perspective on results of surveys that seek the opinion of referring clinicians about oncologic 18F-FDG PET/CT reporting and previews an article on this topic in this issue of JNM.

Page 1923

Perception of PET/CT misinterpretation: Karantanis and colleagues detail results of a study designed to collect pertinent information from physicians referring patients for oncologic 18F-FDG PET/CT, with surprising findings about clinicians’ most frequent complaint.

Page 1925

DWI in whole-body PET/MR: Grueneisen and colleagues assess the diagnostic benefit of diffusion-weighted imaging in an 18F-FDG PET/MR protocol for whole-body staging of women with primary or recurrent malignancies of the pelvis.

Page 1930

International use of PET in DLBCL: Carr and colleagues report on a multinational study of PET for risk stratification in diffuse large B-cell lymphoma and ask whether biologic and health care system diversity influence response as assessed by interim PET.

Page 1936

99mTc-folate M2 macrophage plaque imaging: Jager and colleagues explore the presence of activated macrophages in human atherosclerotic plaques with 99mTc-folate imaging and evaluate whether this technique can discriminate between M1- and M2-like macrophage phenotypes.

Page 1945

MBF methods for 82Rb: Murthy and colleagues compare differences among multiple methods and models for quantification of myocardial blood flow and myocardial flow reserve using 82Rb PET and assess their impact on prognostic assessment in a large clinical dataset.

Page 1952

PET and SPECT in dementia: O’Brien and colleagues investigate the comparative diagnostic accuracy of 18F-FDG PET and HMPAO SPECT in individuals with Alzheimer disease or dementia with Lewy bodies.

Page 1959

123I-CLINDE SPECT: Feng and colleagues provide a method for and documentation of quantification of translocator protein binding using SPECT and a promising ligand in patients with cerebral stroke or glioblastoma multiforme.

Page 1966

18F-mefway characterization: Hillmer and colleagues examine in humans the in vivo cerebral binding profile and metabolism of this serotonin-1A receptor that is implicated in an array of neurologic and psychiatric disorders.

Page 1973

Scintigraphic imaging of endocarditis: Rouzet and colleagues compare the respective performances of 18F-FDG PET and leukocyte scintigraphy for diagnosis of prosthetic valve endocarditis in 39 patients.

Page 1980

FACBC physiologic uptake: Schuster and colleagues explore common physiologic uptake patterns, as well as incidental findings and variants, in patients who have undergone PET imaging with this synthetic amino acid analog.

Page 1986

11C-CURB dosimetry: Boileau and colleagues investigate in humans the whole-body biodistribution and radiation dosimetry of this novel 11C-labeled suicide irreversible tracer developed as a surrogate measure of activity of the fatty acid amide hydrolase.

Page 1993

Dose reduction using SUV: Cheng and colleagues explore how the injected 18F-FDG dose can be lowered while maintaining validity in comparing standardized uptake values between studies.

Page 1998

Multimodality imaging of dementia: Nazrallah and Wolk provide an educational overview of imaging in neurodegenerative dementia, including a focus on the potential for hybrid PET/MR imaging to improve diagnosis and management.

Page 2003

Specific activity of antibody cocktails: Pasternack and colleagues look at ways in which combinations of radiolabeled antibodies can be formulated to overcome the limitations of nonuniform dose distributions among disseminated tumor cells in targeted α therapy.

Page 2012

188Re-P2045 and tumor growth: Nelson and colleagues describe studies designed to determine whether this radiolabeled peptide analog of somatostatin can inhibit pancreatic tumor xenograft growth in a mouse model.

Page 2020

Imaging DNA damage in breast cancer: Cornelissen and colleagues investigate whether 111In-anti-γH2AX-TAT is able to detect the DNA damage response during mammary oncogenesis in mice.

Page 2026

89Zr-labeled immuno-PET and HCC: Sham and colleagues assess the potential of 89Zr-conjugated F(ab′)2 fragments directed against glypican-3 as a diagnostic immuno-PET probe in hepatocellular carcinoma.

Page 2032

18F-FDG uptake in CRC with mutated KRAS: Iwamoto and colleagues explore through in vivo and small-animal studies the mechanisms by which KRAS gene mutations, which occur in ∼40% of colorectal cancers, increase 18F-FDG accumulation.

Page 2038

Immuno-PET targeting of STEAP1: Doran and colleagues describe preparation and evaluation of 89Zr-2109A, a radiotracer for PET derived from a fully humanized monoclonal antibody to cell surface protein 6 transmembrane epithelial antigen of prostate 1 in preclinical prostate cancer models.

Page 2045

GRPR antagonists for prostate cancer PET: Chatalic and colleagues compare 3 novel gastrin-releasing peptide receptor–targeted radiolabeled tracers for PET imaging of prostate cancer.

Page 2050

99mTc-peptide melanoma imaging: Guo and Miao examine the effects of amino acid, hydrocarbon, and polyethylene glycol linkers on the melanoma targeting and imaging properties of several novel 99mTc-labeled peptides.

Page 2057

Myocardial perfusion IQ SPECT: Caobelli and colleagues establish the lower limit of radioactivity that can be administered to patients for myocardial perfusion IQ SPECT and the minimum acquisition time that will preserve diagnostic accuracy.

Page 2064

PET AC from MR: Roy and colleagues detail a PET attenuation correction method using a patch-matching approach to synthesize CT images from ultrashort echo-time MR images, with resulting improvements in PET reconstruction accuracy.

Page 2071

  • © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (12)
Journal of Nuclear Medicine
Vol. 55, Issue 12
December 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Dec 2014, 55 (12) 8A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Dec 2014, 55 (12) 8A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians
  • Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease
  • Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
  • Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
  • Introduction of an 8-Aminooctanoic Acid Linker Enhances Uptake of 99mTc-Labeled Lactam Bridge–Cyclized α-MSH Peptide in Melanoma
  • Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies
  • In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4′-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamide SPECT
  • Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias
  • 18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias
  • Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET
  • Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis
  • Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase
  • Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer
  • Glypican-3–Targeting F(ab′)2 for 89Zr PET of Hepatocellular Carcinoma
  • Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
  • First-in-Human Evaluation of 18F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors
  • Comparison and Prognostic Validation of Multiple Methods of Quantification of Myocardial Blood Flow with 82Rb PET
  • Theranostic Nanoparticles
  • Using SUV as a Guide to 18F-FDG Dose Reduction
  • The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
  • The Customer Is Always Right, Even When You Are Justifiably Wrong
  • The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
  • IQ SPECT Allows a Significant Reduction in Administered Dose and Acquisition Time for Myocardial Perfusion Imaging: Evidence from a Phantom Study
  • Folate Receptor-β Imaging Using 99mTc-Folate to Explore Distribution of Polarized Macrophage Populations in Human Atherosclerotic Plaque
  • PET Attenuation Correction Using Synthetic CT from Ultrashort Echo-Time MR Imaging
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire